Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Dominique Jennings"'
Data from Imaging of Activated T Cells as an Early Predictor of Immune Response to Anti-PD-1 Therapy
Autor:
Henry VanBrocklin, Dominique Jennings, Karl F. Schmidt, Roli Khattri, Joseph E. Blecha, Tony L. Huynh, Salma Jivan, Gang Ren, Jennifer Bates, Shahriar Yaghoubi, Samuel R. Goth, Tina Lam, Jelena Levi
Compelling evidence points to immune cell infiltration as a critical component of successful immunotherapy. However, there are currently no clinically available, noninvasive methods capable of evaluating immune contexture prior to or during immunothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c71f9649b2a300a117a311853069e4e
https://doi.org/10.1158/0008-5472.c.6510801
https://doi.org/10.1158/0008-5472.c.6510801
Autor:
Henry VanBrocklin, Dominique Jennings, Karl F. Schmidt, Roli Khattri, Joseph E. Blecha, Tony L. Huynh, Salma Jivan, Gang Ren, Jennifer Bates, Shahriar Yaghoubi, Samuel R. Goth, Tina Lam, Jelena Levi
FACS analyses, expression of transporters and kinases in immune cells, tumor growth.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a02ee0a3e4a91261fc8f598113019a7d
https://doi.org/10.1158/0008-5472.22420983.v1
https://doi.org/10.1158/0008-5472.22420983.v1
Autor:
Rakesh K. Jain, Tracy T. Batchelor, Percy Ivy, Patrick Y. Wen, Meiyun Wang, Marek Ancukiewicz, Heisoog Kim, Dominique Jennings, Pavlina Polaskova, Kyrre E. Emblem, A. Gregory Sorensen
PDF file - 1.7MB, Figure S2: Changes in Imaging Parameters over Time. Based on the three patients groups from the microvessel tumor flow analysis, the plots show: (A) contrast-enhanced T1-weighted tumor volumes, (B) FLAIR tumor volumes and (C) permea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::215b2ad6b65b5ed344aacd23e1b8d8ac
https://doi.org/10.1158/0008-5472.22393067
https://doi.org/10.1158/0008-5472.22393067
Autor:
Rakesh K. Jain, Dan G. Duda, Emmanuelle di Tomaso, Marek Ancukiewicz, Johanna Lahdenranta, Patrick Y. Wen, Dominique Jennings, Meiyun Wang, Priscilla Yeo, Poe-Jou Chen, Wei-Ting Zhang, Tracy T. Batchelor, A. Gregory Sorensen
Cover image supplementary movie: added 7-15-09 from A “Vascular Normalization Index” as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::931d69027cb7c6ba59864f6f16269d68
https://doi.org/10.1158/0008-5472.22379186.v1
https://doi.org/10.1158/0008-5472.22379186.v1
Autor:
Rakesh K. Jain, Dan G. Duda, Emmanuelle di Tomaso, Marek Ancukiewicz, Johanna Lahdenranta, Patrick Y. Wen, Dominique Jennings, Meiyun Wang, Priscilla Yeo, Poe-Jou Chen, Wei-Ting Zhang, Tracy T. Batchelor, A. Gregory Sorensen
Supplementary Table 1 from A “Vascular Normalization Index” as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c3f12a264403dd3ef6d5a1c0b2342f5
https://doi.org/10.1158/0008-5472.22379180.v1
https://doi.org/10.1158/0008-5472.22379180.v1
Autor:
Rakesh K. Jain, Dan G. Duda, Emmanuelle di Tomaso, Marek Ancukiewicz, Johanna Lahdenranta, Patrick Y. Wen, Dominique Jennings, Meiyun Wang, Priscilla Yeo, Poe-Jou Chen, Wei-Ting Zhang, Tracy T. Batchelor, A. Gregory Sorensen
Supplementary Figures 1-4 from A “Vascular Normalization Index” as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f2bad3134ea4bb38f5529edaacb9911
https://doi.org/10.1158/0008-5472.22379183
https://doi.org/10.1158/0008-5472.22379183
Autor:
Rakesh K. Jain, Tracy T. Batchelor, Percy Ivy, Patrick Y. Wen, Meiyun Wang, Marek Ancukiewicz, Heisoog Kim, Dominique Jennings, Pavlina Polaskova, Kyrre E. Emblem, A. Gregory Sorensen
PDF file - 5.2MB, Figure S1: Decreased Flow. Representative example of patient with flow decrease. (A) Anatomic MR imaging showing decrease in the contrast enhanced tumor area. (B) Flow maps showing decreasing flow. The blue ovals indicate region of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b2f3ffb02291bf51eb9ebe32aac2c72
https://doi.org/10.1158/0008-5472.22393070
https://doi.org/10.1158/0008-5472.22393070
Autor:
Rakesh K. Jain, Tracy T. Batchelor, Percy Ivy, Patrick Y. Wen, Meiyun Wang, Marek Ancukiewicz, Heisoog Kim, Dominique Jennings, Pavlina Polaskova, Kyrre E. Emblem, A. Gregory Sorensen
PDF file - 894K, Figure S5: Arterial Spin Labeling (ASL) Flow and Response to Treatment. (A) Analysis of blood flow as measured by arterial spin labeling (ASL) when applying the patients groups from the macrovessel tumor flow analysis. (B) ASL blood
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7bcece93dd3783e3b159cfcd7ce9c50
https://doi.org/10.1158/0008-5472.22393058
https://doi.org/10.1158/0008-5472.22393058
Autor:
Rakesh K. Jain, Tracy T. Batchelor, Percy Ivy, Patrick Y. Wen, Meiyun Wang, Marek Ancukiewicz, Heisoog Kim, Dominique Jennings, Pavlina Polaskova, Kyrre E. Emblem, A. Gregory Sorensen
PDF file - 1.3MB, Figure S4: Macrovessel Flow and Response to Treatment. (A) Similar to microvessel flow, analysis of total (macrovessel) flow show three types of response to anti-angiogenic treatment: increase in flow (6 patients), stable flow (13 p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46d2edfc5c1e98f72d421fe3675c0cbe
https://doi.org/10.1158/0008-5472.22393061
https://doi.org/10.1158/0008-5472.22393061
Autor:
Rakesh K. Jain, Dan G. Duda, Emmanuelle di Tomaso, Marek Ancukiewicz, Johanna Lahdenranta, Patrick Y. Wen, Dominique Jennings, Meiyun Wang, Priscilla Yeo, Poe-Jou Chen, Wei-Ting Zhang, Tracy T. Batchelor, A. Gregory Sorensen
Early imaging or blood biomarkers of tumor response are desperately needed to customize antiangiogenic therapy for cancer patients. Anti–vascular endothelial growth factor (VEGF) therapy can “normalize” brain tumor vasculature by decreasing ves
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::496bc7dd000675b6894c95f6ab5ab2f5
https://doi.org/10.1158/0008-5472.c.6499169.v1
https://doi.org/10.1158/0008-5472.c.6499169.v1